BSX financials
Boston Scientific (BSX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
- BSX revenue was $20.07B in fiscal 2025, net income $2.90B.
BSX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $20.07B | $13.85B | $3.61B | $2.90B | 1.94 |
| 2024 | $16.75B | $11.49B | $2.60B | $1.85B | 1.25 |
| 2023 | $14.24B | $9.90B | $2.34B | $1.57B | 1.07 |
| 2022 | $12.68B | $8.73B | $1.65B | $642.00M | 0.45 |
| 2021 | $11.89B | $8.18B | $1.20B | $985.00M | 0.69 |
| 2020 | $9.91B | $6.45B | -$80.00M | -$115.00M | -0.08 |